SCHEMBL5846192

SCHEMBL5846192

CCC(=O)OC1CC1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15305155 0.85 CHRM2 (0.41)
SCHEMBL17142328 0.83 CHRM2 (0.45)
Hydrochloric Acid SCHEMBL28913389 0.81 CHRM2 (0.44)
SCHEMBL2498680 0.79 CHRM2 (0.46)
SCHEMBL3744068 0.79 CHRM2 (0.46)
SCHEMBL7499029 0.79
Hydrochloric Acid SCHEMBL29220641 0.78 CHRM2 (0.45)
SCHEMBL25084544 0.76 CHRM2 (0.39)
SCHEMBL28129853 0.74 CHRM2 (0.53)
SCHEMBL27641293 0.74 CHRM2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105142635-A Heterocyclic compounds useful in treatment of disease EPIGEN BIOSCIENCES INC 2015-12-09 CN disclosed
CN-101184769-A Diagnostic and therapeutic agents KARYON CTT LTD (FI) 2008-05-21 CN disclosed
US-7132539-B2 Melanocortin receptor ligands THE PROCTER & GAMBLE COMPANY (US) 2006-11-07 US disclosed
US-20060247224-A1 Melanocortin receptor ligands THE PROCTER & GAMBLE COMPANY 2006-11-02 US disclosed
CN-1227248-C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent AVENTIS PHARMA GMBH (DE) 2005-11-16 CN disclosed
CN-1221535-C Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them AVENTIS PHARMA GMBH (DE) 2005-10-05 CN disclosed
EP-1556361-A2 2-ALKYL-(2-AMINO-3-ARYL-PROPIONYL)-PIPERAZINE DERIVATIVES AND RELATED COMPOUNDS AS MELANOCORTIN RECEPTOR LIGANDS FOR THE TREATMENT OF OBESITY THE PROCTER & GAMBLE COMPANY (US) 2005-07-27 EP disclosed
US-20050010031-A1 Melanocortin receptor ligands THE PROCTER & GAMBLE COMPANY 2005-01-13 US disclosed
CN-1496360-A Imidazolidine derivatives, their preparation, and their use as antinflamatory agent ������ҽҩ�¹����޹�˾ 2004-05-12 CN disclosed
WO-2004037797-A2 2 - ALKYL - (2 - AMINO - 3 - ARYL - PROPIONYL) - PIPERAZINE DERIVATIVES AND RELATED COMPOUNDS AS MELANOCORTIN RECEPTOR LIGANDS FOR THE TREATMENT OF OBESITY THE PROCTER & GAMBLE COMPANY (US) 2004-05-06 WO disclosed
US-6498161-B1 TREATING INFECTION BY HIV; DELAYING OF THE ONSET OF AIDS; ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS OR RHEUMATOID ARTHRITIS MERCK & CO., INC. 2002-12-24 US disclosed
CN-1356986-A Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical prepns. comprising them AVENTIS PHARMA GMBH (DE) 2002-07-03 CN disclosed
US-6399619-B1 PREVENTION AND TREATMENT OF AIDS AND VIRAL INFECTION BY HIV MERCK & CO., INC. 2002-06-04 US disclosed
EP-1171122-A4 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO INC (US) 2002-05-29 EP disclosed
EP-1171122-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Merck & Co., Inc. (US) 2002-01-16 EP disclosed
US-6248755-B1 ANTIINFLAMMATORY AGENTS; ANTIALLERGENS; AUTOIMMUNE DISEASES MERCK & CO., INC. 2001-06-19 US disclosed
WO-2000059498-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-10-12 WO disclosed
WO-2000059502-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-10-12 WO disclosed
WO-2000059497-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-10-12 WO disclosed